Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual‐Tracer Positron Emission Tomography Imaging Study

This study examined the relationship between DAT and overall synaptic density in nigrostriatal ROIs in PD using dual-tracer PET imaging, and there were distinct patterns that vary across disease stages. Understanding the interplay between dopaminergic and presynaptic degeneration in PD could enhance our knowledge of its pathophysiology and contribute to improve diagnosis. © 2025 International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-10-03
DOI
https://doi.org/10.1002/mds.70041
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual‐Tracer Positron Emission Tomography Imaging Study

Jean‐Dominique Gallezot, Gustavo A. Angarita, Richard E. Carson, Faranak Ebrahimian Sadabad et al.
Movement Disorders
Parkinson's Disease Mechanisms and Treatments
article

Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual‐Tracer Positron Emission Tomography Imaging Study

Jean‐Dominique Gallezot, Gustavo A. Angarita, Richard E. Carson, Faranak Ebrahimian Sadabad, Yanghong Yang, Robert A. Comley, Takuya Toyonaga, Sophie Holmes, Waleed Ibrahim, Rajiv Radhakrishnan, Mark Dias, Mika Naganawa, Brian Pittman, Tommaso Volpi, Sjoerd J. Finnema, Sule Tinaz, Praveen Honhar, David Matuskey, Salih Çayır
article en

Abstract

This study examined the relationship between DAT and overall synaptic density in nigrostriatal ROIs in PD using dual-tracer PET imaging, and there were distinct patterns that vary across disease stages. Understanding the interplay between dopaminergic and presynaptic degeneration in PD could enhance our knowledge of its pathophysiology and contribute to improve diagnosis. © 2025 International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(12)
AbbVie (United States) (US), Yale University (US)
Openalex Percentile: Top 61%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual‐Tracer Positron Emission Tomography Imaging Study — Jean‐Dominique Gallezot, Gustavo A. Angarita, et al. · Movement Disorders (2025) | TGRS Research Map | TGRS